The William B. Abrams Lecture is a joint educational initiative of ASCPT and the FDA. The lecture series, supported in part by The Merck Company Foundation, was established in 1999 to honor William B. Abrams, MD, an ASCPT president from 1975 to 1976.
Among his many accomplishments, Dr. Abrams worked at the FDA as the first special government employee to establish the Center for Drug Evaluation and Research Staff College and develop its curriculum. He also had a distinguished career in the pharmaceutical industry as a longtime employee of Merck Research Laboratories.
For more than 10 years, ASCPT and the FDA have invited experts from academia, industry, and government to discuss advances in clinical pharmacology and drug development. These scientists have excelled in their specialty areas and are some of the most highly esteemed clinical pharmacologists in the field. Their presentations convey novel information and perspectives on fundamental aspects of clinical pharmacology. Previous lectures have included speakers from the Mayo Clinic, University of California, Children's Mercy Hospitals and Clinics, and the National Institutes of Health.
2023 ASCPT & FDA William B. Abrams Lecture
The 2023 ASCPT & FDA William Abrams Lecture Award recipient is Namandjé Bumpus, PhD, Chief Scientist, at the FDA.
: Mechanistic Studies in Drug Metabolism and Single Cell Biology to Advance Clinical Pharmacology
Date & Time
: Tuesday, May 30, 2023, 1:00- 2:30 pm ET
*Lecture will be presented virtually.
This activity is intended for physicians, pharmacists, nurses, FDA scientific community, and other health professionals who review medical products, perform regulatory science research, and set regulatory science policy.
If you have any questions about the ASCPT & FDA Abrams Award please contact Elise Laffman-Johnson